Deucravacitinib Long-Term Efficacy in Week 16 Placebo Crossovers: 3-year Results from the POETYK PSO Program. J of Skin [Internet]. 2024 Mar. 18 [cited 2026 May 2];8(2):s365. Available from: https://skin.dermsquared.com/skin/article/view/2672